hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more


HMGUi001-A-46

Registration Summary:

ARX-CFP/PAX4-mCherry, ARX-T2A-H2B-CFP/H2B-mCherry-RGSHis-T2A-PAX4, ARXnCFP/nCFP/PAX4mCherry/mCherry

HMGUi001-A-46

General

Cell Line
hPSCreg name HMGUi001-A-46
Cite as:
HMGUi001-A-46
Alternative name(s)
ARX-CFP/PAX4-mCherry, ARX-T2A-H2B-CFP/H2B-mCherry-RGSHis-T2A-PAX4, ARXnCFP/nCFP/PAX4mCherry/mCherry
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
HMGUi001-A
(XM001, BIHi043-A)
HMGUi001-A-8
(C-PEP-mCherry-hiPSC)
HMGUi001-A-43
(hINS-T2A-H2B-Cherry (-/-), hiPSC-INS-T2A-H2B-Cherry reporter, INSCherry/Cherry)
HMGUi001-A-5
(ΔINK4 T2D risk region hiPSC)
HMGUi001-A-42
(NEUROD2 nVenus/nVenus iPSCs)
HMGUi001-A-1
(hINS-T2A-H2B-Cherry (+/-), HMGUi001-A-1)
HMGUi001-A-4
(hiPSC-ARX-T2A-H2B-CFP-Flag)
HMGUi001-A-22
(NCS1-KO Clone 19)
Last update 12th August 2024
Notes This line is a subclone of HMGUi001-A-4.
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider
Generator Institute of Diabetes and Regeneration Research (IDR)
Owner Institute of Diabetes and Regeneration Research (IDR)
Distributors
Derivation country Germany

External Databases
BioSamples SAMEA115108855

General Information
Publications
* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information
Sex female
Ethnicity Caucasian

Phenotype and Disease related information (Donor)
Diseases No disease was diagnosed.
Family history no
Is the medical history available upon request? no
Is clinical information available? no

Other Genotyping (Donor)
Is there genome-wide genotyping or functional data available?
No

Donor Relations
Other cell lines of this donor

External Databases (Donor)
BioSamples SAMEA5696688

Ethics

Also have a look at the ethics information for the parental line HMGUi001-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Vectors were generated at IDR, pU6-(BbsI)-sgRNA-CAG-Cas9-Venus-bpA plasmid (Addgene plasmid #86986) was used.
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? Yes
Constraints for use or distribution According to donor consent the line must not be used for commercial purposes. For research purposes project-specific review by a medical Ethics Committee is obligatory.

hIPSC Derivation

General
The source cell information can be found in the parental cell line HMGUi001-A.
Passage number reprogrammed 40

Reprogramming method
Vector type Non-integrating
Vector The Pax4 locus of HMGUi001 -A-4 hiPSC line was targeted with two vectors. For the first vector, the Cas9- Venus- sgRNA vector, a sgRNA was cloned into the pU6- (BbsI)-sgRNA-CAG- Cas9-Venus- bpA plasmid (Addgene plasmid #86986). Cas9 and a targeting site specific sgRNA were expressed from this vector to induce a double strand break at the targeting region. The second vector contained H2B-mCherry-RGSHis-T2A-PAX4 construct for the intended homology directed repair: the mCherry coding sequence flanked by a 703 bp left homology arm (5’ HA) and a 1009 bp right homology arm (3’ HA).

Vector free reprogramming

Other
Selection criteria for clones Transfected cells expressed Venus and were sorted by FACS. The genotype of the clones was screened by PCR and verified by Sanger sequencing.
Derived under xeno-free conditions
Yes
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: StemMACS iPS-Brew XF medium
Main protein source: xeno-free
Serum concentration: 0 %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
POU5F1 (OCT-4)
Yes
SSEA-4
Yes
TRA 1-60
Yes
Oct-3
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Marker Expressed
SOX17
Yes
FOXA2
Yes
Mesoderm
Ont Id: UBERON_0000926
Marker Expressed
SM22-alpha
Yes
SNAIL1
Yes
Ectoderm
Ont Id: UBERON_0000924
Marker Expressed
Nestin
Yes
Tubulin
Yes

Microbiology / Virus Screening
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)
Has the cell line karyotype been analysed?
Yes
46, XX
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
Transgene expression
Chromosome 7, Pax4 gene, exon 2
The ARX-CFP/PAX4-mCherry double resporter transgenicli ne p resented here was gene rated by homozygous insertion of the mCherry sequence at the C-terminus of the PAX4 in ARX-nCFP/nCFP hiPSC line.